Merck & Company, Inc.
做多

Long $MRK

208
- MRK is a quality compounder selling at a discount.

Year | 2025 | 2026 | 2027 | 2028
EPS | 8.90 | 9.72 | 10.65 | 10.38
EPS% | 18.36% | 9.21% | 9.54% | -2.52%


Conservative forward p/e should be 10

Fair Stock value:
EPS | 8.90 | 9.72 | 10.65 | 10.38
Price | 89 | 97 | 106 | 103

Positive Suprises or rotation into healthcare by fund manager would leead to forward p/e of 15

EPS | 8.90 | 9.72 | 10.65 | 10.38
Stock price | 133 | 145 | 159 | 155
註釋
Bullish: Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda
註釋
Let's go MRK
註釋
MRK has entered my target range box
註釋
Fair value for MRK in 2026 is $135-145

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。